clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Update Preferences
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
Molecular Dx
Combining Blood Test with Clinical Score Offers Breakthrough for Stroke Detection
News & Features
New Protein Marker Identified for Breast Cancer Prognosis
Molecular Dx
Cord Blood Proteomic Profile May Help Predict Baby Growth Trajectories
News & Features
AI Could Automate Oropharyngeal Cancer Staging
News & Features
Can New Biomarker Data Improve Cardiovascular Risk Assessment?
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Takeda Signs Deal Worth $2.2 Billion with AC Immune for Alzheimer’s Vaccine
Phase I clinical trials (Clinical trial)
News & Features
Takeda Signs Deal Worth $2.2 Billion with AC Immune for Alzheimer’s Vaccine
Helen Albert
-
May 13, 2024
0
News & Features
Verve Starts Second Human Cardiovascular Gene Therapy Trial
Helen Albert
-
May 7, 2024
0
News & Features
mRNA Cancer Vaccine Reprograms Immune System to Tackle Glioblastoma
Sophia Ktori
-
May 1, 2024
0
News & Features
CAR T-Cell Therapy for Sarcoma Shows Early Promise
Helen Albert
-
April 24, 2024
0
News & Features
Next-Generation T Cell Therapy Shows Promise For Solid Tumors
Laura Cowen
-
April 3, 2024
0
News & Features
CAR T-Cell Therapy Successfully Used to Treat Brain Tumors
Camille Mojica Rey, Ph.D.
-
March 13, 2024
0
News & Features
Sionna Raises $182M for Novel Cystic Fibrosis Drug Candidates
Malorye Branca
-
March 7, 2024
0
News & Features
Insulin Delivered via Nano-Carriers May Pave Way for Oral Diabetes Treatment
Chris Anderson
-
January 22, 2024
0
News & Features
BMS Dives Deeper into ADCs with Potential $8.4B SystImmune Deal
Malorye Branca
-
December 12, 2023
0
News & Features
CAR T-Cell Therapy with New Binding Method Shows Early Promise
Helen Albert
-
December 11, 2023
0
1
2
3
4
Page 1 of 4
Related Content
New Protein Marker Identified for Breast Cancer Prognosis
Personal Vaccine Combined with Immune-Boosting Agent Improves Treatment of Malignant Glioma
Verve Starts Second Human Cardiovascular Gene Therapy Trial
New Vaccine Approach Offers Protection from Coronaviruses That Haven’t Yet Emerged
Inside Precision Medicine